Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine
- PMID: 2552175
- PMCID: PMC251143
- DOI: 10.1128/JVI.63.11.4949-4951.1989
Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine
Abstract
Infectious cDNAs of the Sabin type 2 poliovirus vaccine virus and a vaccine-derived neurovirulent type 2 strain (P2/117) have been cloned in Escherichia coli. Nucleotide sequence analysis revealed that P2/117 differs from the vaccine strain by just 23 point mutations. Three occur in the 5' noncoding region. The remainder result in a total of 5 coding changes located in VP1, VP4, 2B, and 3D. The likely role of these mutations in the evolution to neurovirulence is discussed.
Similar articles
-
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.J Virol. 1989 Mar;63(3):1338-44. doi: 10.1128/JVI.63.3.1338-1344.1989. J Virol. 1989. PMID: 2536836 Free PMC article.
-
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.Nucleic Acids Res. 1984 Oct 25;12(20):7787-92. doi: 10.1093/nar/12.20.7787. Nucleic Acids Res. 1984. PMID: 6093054 Free PMC article.
-
Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.Eur J Biochem. 1983 Oct 3;135(3):529-33. doi: 10.1111/j.1432-1033.1983.tb07684.x. Eur J Biochem. 1983. PMID: 6311539
-
Strategy for construction of live picornavirus vaccines.Vaccine. 1988 Apr;6(2):134-7. doi: 10.1016/s0264-410x(88)80015-x. Vaccine. 1988. PMID: 2838985 Review.
-
Poliovirus neurovirulence.Adv Virus Res. 1988;34:217-46. doi: 10.1016/s0065-3527(08)60519-9. Adv Virus Res. 1988. PMID: 2843017 Review. No abstract available.
Cited by
-
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.Cell Host Microbe. 2020 May 13;27(5):736-751.e8. doi: 10.1016/j.chom.2020.04.003. Epub 2020 Apr 23. Cell Host Microbe. 2020. PMID: 32330425 Free PMC article. Clinical Trial.
-
Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.Vaccines (Basel). 2020 Jan 21;8(1):36. doi: 10.3390/vaccines8010036. Vaccines (Basel). 2020. PMID: 31973073 Free PMC article. Review.
-
Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.J Virol. 2018 Apr 13;92(9):e01949-17. doi: 10.1128/JVI.01949-17. Print 2018 May 1. J Virol. 2018. PMID: 29444940 Free PMC article.
-
The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication.J Virol. 2013 Oct;87(20):11031-46. doi: 10.1128/JVI.00304-13. Epub 2013 Aug 7. J Virol. 2013. PMID: 23926333 Free PMC article.
-
Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Risk Anal. 2013 Apr;33(4):680-702. doi: 10.1111/risa.12022. Epub 2013 Mar 7. Risk Anal. 2013. PMID: 23470192 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources